Logo.png
CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
11 juin 2024 09h00 HE | CanaQuest Medical Corp.
Appointee, formerly with GW Pharma (subsidiary), brings extensive expertise in cannabinoid therapeutics, including the FDA-approved launch of cannabidiol (Epidiolex®) TORONTO, ON, June 11, 2024 ...
Straits Research Pvt Ltd
Drug Discovery Informatics Market Size is expected to reach USD 7.44 billion by 2031, growing at a CAGR of 10.8%: Straits Research
18 mars 2024 09h30 HE | Straits Research Private Limited
New York, United States, March 18, 2024 (GLOBE NEWSWIRE) -- Drug discovery informatics continues to revolutionize the field of drug discovery by leveraging cutting-edge technologies and...
Straits Research Pvt Ltd
Global Drug Discovery Market Size is Expected to Reach USD 120,809 million by 2030: Straits Research
05 déc. 2023 10h10 HE | Straits Research
New York, United States, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Drug discovery is the process of examining potential novel treatments, and it takes place in the domains of pharmacology, biotechnology,...
Syntekabio-1
Syntekabio (KOSDAQ:226330.KQ) Presents Neoantigen Prediction Technology at Cancer Immunotherapy Conference CICON22
26 sept. 2022 15h07 HE | Syntekabio
New York, N.Y., United States, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ:226330.KQ), a global AI drug discovery and development company, will present its neoantigen prediction technology...
factMR-logo.png
Shift Towards Personalized Medicines, Which Is Expected To Fuel The Growth Of The Antimicrobial Susceptibility Test Market
06 sept. 2022 06h00 HE | FACT.MR
Dublin, Ireland, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Fact.MR – A Market Research and Competitive Intelligence Provider: Rise in government initiatives related to the development of quality hospital...
Logo-InveniAI.png
InveniAI and Kyowa Kirin Announce Achievement of Milestone in Research Collaboration
31 mai 2022 08h15 HE | InveniAI LLC
GUILFORD, Conn. and TOKYO, May 31, 2022 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug and target discovery...
Logo (3).png
Antimicrobial Susceptibility Testing Market Worth $5.99 billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®
05 oct. 2021 07h26 HE | Meticulous Market Research Pvt. Ltd.
Redding,  California, Oct. 05, 2021 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Antimicrobial Susceptibility Testing Market by Product (Manual {Susceptibility Discs,...
Photo
InveniAI Appoints Industry Leader Dr. Salvatore Alesci as Chief Scientific Officer to Advance AI-Powered Portfolio of Assets Targeting Dysregulation of the Gut-Brain Axis
11 mai 2021 08h10 HE | InveniAI LLC
Pipeline to include new chemical entities as well as re-innovated drugs, all targeting dysregulation of the gut-brain axis and inflammasome pathways for chronic inflammatory diseasesDr. Alesci’s...
fior-markets-logo.jpg
Global Antimicrobial Susceptibility Test Market Is Expected to Reach USD 7.57 billion by 2027 : Fior Markets
09 sept. 2020 19h00 HE | Fior Markets
Newark, NJ, Sept. 09, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global antimicrobial susceptibility test market is expected to grow from USD 4.58 billion in 2019 and...
Logo-InveniAI.png
InveniAI Announces Strategic Partnership with TB Alliance to Advance the Development of Transformative Therapies for Tuberculosis
02 juin 2020 08h00 HE | InveniAI
GUILDFORD, Conn., June 02, 2020 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across...